The Power of Pharmacist Interventions in Improving Glycemic Control for Diabetes Patients: A Multicenter Study in Malaysia

By Staff Writer

July 10, 2023

A recent study conducted in Malaysia has shed light on the significant impact of pharmacist interventions on glycemic control in diabetic patients. The study, which focused on the Diabetes Medication Therapy Adherence Clinic (DMTAC) program, revealed a substantial reduction in HbA1c levels among patients after their visits to the clinic.

The findings of this study were consistent with previous smaller-scale studies conducted in a health clinic and a tertiary hospital in Malaysia. These studies also demonstrated a significant reduction in HbA1c levels among diabetic patients. Additionally, the study found that patients who did not default from follow-up visits achieved significantly lower HbA1c levels compared to those who did default.

Several factors were identified as independent predictors of HbA1c levels, including the frequency of DMTAC visits, duration of diabetes, number of dosage adjustments, and the use of antidiabetic agents. The study also highlighted the overall improvement in HbA1c levels among all subjects, including the defaulters, from baseline until post-2 (up to a year).

The study emphasized the need for adherence to follow-up schedules in diabetes clinics, as patients who adhered to DMTAC follow-up experienced a greater reduction in HbA1c levels. It also highlighted the potential benefits of a more holistic and multidisciplinary approach to treating diabetic patients, such as combining different clinics and reducing the number of follow-ups.

While there was no significant difference in glycemic control between patients who visited DMTAC in hospitals and primary health clinics, a higher default rate was observed in hospital patients. This suggests the need to strengthen primary health care and optimize its utilization among diabetes patients.

The study also analyzed the predictors that led to HbA1c reduction and found that more frequent DMTAC visits during the initial phase had a positive impact on glycemic control. However, this impact was not observed in the second phase of follow-up. Optimization of diabetic treatment, particularly through pharmacist-led interventions such as dosage adjustment and the addition of antidiabetic agents, significantly improved glycemic control in the longer term.

This real-world study provides valuable insights into the factors and interventions associated with improved glycemic control in diabetes patients. It highlights the crucial role of pharmacists in diabetes care and offers guidance to policymakers in determining key performance indicators in DMTAC.

Reference url

Recent Posts

diabetes medicine access
               

Improving Diabetes Medicine Access: Key Changes in the Pharmaceutical Benefits Scheme

🚀 Are we on the verge of a breakthrough in diabetes medication accessibility?

The latest updates to the Pharmaceutical Benefits Scheme (PBS) are set to transform type 2 diabetes management by expanding access to essential medicines like empagliflozin and streamlining the prescribing process for glucagon-like peptide 1 receptor agonists (GLP-1 RAs). These changes not only prioritize equity for high-risk populations but also align with global trends in cost-effective healthcare.

Dive deeper into how these revisions could reshape diabetes care and promote better health outcomes for all.

#SyenzaNews #HealthcareInnovation #healthcare #MarketAccess

HPV testing HNSCC
    

HPV Testing in Head and Neck Squamous Cell Carcinoma

🔍 Are you up-to-date with the latest advancements in HPV testing for head and neck cancer?

Our comprehensive article looks into the innovation of diagnostic methods for HPV status determination in head and neck squamous cell carcinoma (HNSCC). From traditional p16 immunohistochemistry to innovative liquid biopsies, discover the critical role these advancements play in prognosis, treatment planning, and improving patient outcomes.

Look into this essential topic and see how these insights could revolutionize clinical practices.

#SyenzaNews #oncology #HealthTech #HealthcareInnovation

oral health Africa
    

Oral Health in Africa: Promoting Collaborative Solutions

🦷 Is oral health taking a back seat in public health discussions in Africa?

A new article reveals alarming statistics about the high prevalence of untreated dental diseases across the continent and a critical shortage of oral health professionals. It emphasizes the urgent need for collaborative action among healthcare providers and policy-makers to integrate oral health into broader public health frameworks.

Discover how strengthening partnerships can pave the way for improved health outcomes and resource allocation in oral health.

#SyenzaNews #globalhealth #HealthEconomics

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.